;

The Thalidomide tragedy will always remain a part of our company’s history. We will never forget what happened, and we deeply regret the wide-ranging consequences for the people affected and their families. On this page, you will find information about Thalidomide and how Grünenthal currently provides support to Thalidomide-affected people.

Our responsibility:
How Grünenthal supports people affected by Thalidomide today

 

As the company that distributed Thalidomide at the time, we believe it is a matter of moral importance that we are actively involved in charitable efforts to improve the situation of Thalidomide-affected people. For this reason, we established the Grünenthal Foundation. There is also a worldwide financial resource system through which affected people can receive support.
... > Learn more

The history of the Thalidomide tragedy

 

The Thalidomide tragedy continues to impact the lives of those affected and their families. Here, we take a look at the series of historical events that shaped the tragedy: from the fate of the “Thalidomide babies” through to the criminal proceedings against nine senior executives from Grünenthal and the creation of the Contergan Foundation.
... > Learn more

Thalidomide:
The substance and its consequences

 

What is Thalidomide? How does it act in the body? How is it used today? We provide an overview of the science, its development, and new pharmacological uses of the drug by other companies.
... > Learn more

News

Current developments on the subject of Thalidomide.

12/14/2020

50 years ago today, the Aachen Regional Court terminated the Thalidomide proceedings against nine Grünenthal senior employees. The criminal trial is still considered one of the most complex and costly proceedings in German legal history. The legal and medical questions concerning the Thalidomide tragedy were complex and difficult to answer.

Contact

Contact information for journalists and Thalidomide-affected people

Fabia Kehren

Contact for the public


Global Communications Grünenthal GmbH


Phone +49 (0) 241 569 3269

E-Mail Fabia.Kehren@grunenthal.com

Tom Hermes

Contact for people affected by Thalidomide


The Grünenthal Foundation for the Support of Thalidomide-Affected People


Phone +49 (0) 241 569 2742

E-Mail tom.hermes@grunenthal-stiftung.com